Increased Mortality Risks of Pre-Diabetes (Impaired Fasting Glucose) in Taiwan
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—The objective of this article was to assess mortality risks at different levels of fasting blood glucose (FBG) in Taiwan, with particular attention to those pre-diabetic subjects with impaired fasting glucose (IFG). RESEARCH DESIGN AND METHODS—Governmental employees and schoolteachers were followed up for an average of 11 years. With the use of Cox regression analyses, mortality risks were calculated for 36,386 subjects, aged 40–69. RESULTS—FBG ≥110 mg/dl was associated with increased mortality risks for all causes, cardiovascular diseases (CVD), and diabetes. IFG, when defined as 110–125 mg/dl, was associated with a significant increase for CVD and/or diabetes mortality. These mortality risks remained elevated when known CVD risk factors were adjusted for. The IFG group shared risk factor characteristics more with the FBG ≥126 mg/dl group than with the FBG <110 mg/dl group. When IFG was defined as 100–125 mg/dl, the number of subjects quadrupled, but mortality risks diminished substantially because of the inclusion of 100–109 mg/dl group. The lowest FBG group, 50–75 mg/dl, had a significant 2-fold risk from all causes. CONCLUSIONS—There was an overall J-shaped relationship between all-cause mortality and FBG. IFG, when defined as 110–125 mg/dl, is an independent risk factor and should be aggressively treated as a disease because its subsequent mortality risks for CVD and diabetes were significantly increased. The newly defined IFG at 100–125 mg/dl did not have the predictive power for later increases in CVD or diabetes mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
Glucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
(2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.397 · Cited by 1,371
(1999) · The Lancet · doi:10.1016/s0140-6736(98)12131-1 · Cited by 1,313
Tominaga, M., Eguchi, H., Manaka, H., Igarashi, K., Kato, T., & Sekikawa, A. (1999) · Diabetes Care · doi:10.2337/diacare.22.6.920 · Cited by 1,165
Gæde, P., Vedel, P., Parving, H.-H., & Pedersen, O. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07368-1 · Cited by 981 · cited 1×
“Nevertheless, the recent change reflected the trend to lower the cut point for either diabetes or pre-diabetes by the American Diabetes Association (ADA) and the World Health Organization (WHO) (1,4), with the expectation that progression of pre-diabetes into diabetes or the development of cardiovascular diseases (CVD…”
BackgroundDiagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2005) · Diabetes Care · doi:10.2337/diacare.28.suppl_1.s37 · Cited by 830
The DECODE Study Group, & on behalf of the European Diabetes Epidemiology Group (2003) · Diabetes Care · doi:10.2337/diacare.26.3.688 · Cited by 516
Blood glucose and risk of cardiovascular disease in the Asia Pacific region.
Asia Pacific Cohort Studies Collaboration (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2836 · Cited by 302
Cited by
Wen, C. P., David Cheng, T. Y., Tsai, S. P., Chan, H. T., Hsu, H. L., Hsu, C. C., & Eriksen, M. P. (2009) · Public Health Nutrition · doi:10.1017/s1368980008002802 · Cited by 543
Self-citationDiagnosis and Management of Prediabetes: A Review
Echouffo-Tcheugui, J. B., Perreault, L., Ji, L., & Dagogo-Jack, S. (2023) · JAMA · doi:10.1001/jama.2023.4063 · Cited by 473
Prediabetes and what it means: the epidemiological evidence
Echouffo-Tcheugui, J. B., & Selvin, E. (2021) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-090419-102644 · Cited by 406
Impact of Impaired Fasting Glucose on Cardiovascular Disease
Levitzky, Y. S., Pencina, M. J., D’Agostino, R. B., Meigs, J. B., Murabito, J. M., Vasan, R. S., & Fox, C. S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.038 · Cited by 278
Matsushita, K., Blecker, S., Pazin-Filho, A., Bertoni, A., Chang, P. P., Coresh, J., & Selvin, E. (2010) · Diabetes · doi:10.2337/db10-0165 · Cited by 183
Metadata
- Authors
- Wen, C. P., Cheng, T. Y. D., Tsai, S. P., Hsu, H. L., & Wang, S. L.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2005-11-01
- Volume
- 28
- Issue
- 11
- Pages
- 2756-2761
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2042753656
- Cited by
- 105
- References
- 13
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased Mortality Risks of Pre-Diabetes (Impaired Fasting Glucose) in Taiwan. https://app.cochat.ai/papers/10.2337/diacare.28.11.2756
- The paper
- Wen, C. P., Cheng, T. Y. D., Tsai, S. P., Hsu, H. L., & Wang, S. L. (2005). Increased Mortality Risks of Pre-Diabetes (Impaired Fasting Glucose) in Taiwan. Diabetes Care. https://doi.org/10.2337/diacare.28.11.2756
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.